In addition, for TLR2, in the glioma TME, TLR2 activation in microglia induces downregulation of MHC class II expression in microglia, thereby limiting T cell-dependent antitumor immunity and promoting glioma immune evasion. The gene discussed is TLR2; the disease is glioma.